Lv69
1620 积分 2024-08-28 加入
Subcutaneous (SC) lecanemab is predicted to achieve comparable efficacy and improved safety compared to lecanemab IV in early Alzheimer’s disease (AD)
3个月前
已完结
Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial
7个月前
已完结
Major depressive disorder: Biomarkers and biosensors
11个月前
已完结
FDA approves first oral drug for postpartum depression, but rejects it for major depressive disorder
11个月前
已完结
Zuranolone for the Treatment of Postpartum Depression
1年前
已完结
围产期精神障碍筛查与诊治专家共识
1年前
已完结
围产期抑郁症筛查与诊治专家共识
1年前
已完结
Estimates of the minimal important difference to evaluate the clinical significance of antidepressants in the acute treatment of moderate-to-severe depression
1年前
已完结
皖公网安备34019202002308
